Quarterly Business Update – December 2022; Sixth Consecutive Quarter of Growth

3 years ago

Cash Receipts Q2 2022 to Year to DateMELBOURNE, Australia, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE,”…

Survey demonstrates that individuals with COPD seek more options to reduce risks of seasonal respiratory viral infections

3 years ago

-- ENA Respiratory and COPD Foundation survey confirms patients are overwhelmingly positive about taking an immune-modulating nasal spray to reduce…

AmMax Bio Announces First Patients Dosed in Phase 2b Study of AMB-05X for the Treatment of Tenosynovial Giant Cell Tumor (TGCT)

3 years ago

Study designed to optimize treatment regimen and evaluate efficacy over six-month dosing period Initial results expected in second half of…

Ring Therapeutics Announces Appointment of Industry Veteran Christopher Wright, M.D., Ph.D. as Chief Medical Officer, Head of Translational Research

3 years ago

CAMBRIDGE, Mass., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Ring Therapeutics, a life sciences company founded by Flagship Pioneering to revolutionize…

MIMEDX Appoints Joseph H. Capper as Chief Executive Officer and Director

3 years ago

Highly experienced and accomplished three-time healthcare CEO with a proven track record of substantial value creation to lead MIMEDX MARIETTA,…

Purple City Labs Introduces OnSight, a Molecular Assay for In-house Testing of Hop Latent Viroid

3 years ago

OAKLAND, Calif., Jan. 27, 2023 (GLOBE NEWSWIRE) -- Purple City Labs, a plant molecular biology company developing germplasm and technologies…

Achieve Life Sciences Announces Granting of New Hire Inducement Award

3 years ago

SEATTLE, Wash and VANCOUVER, British Columbia, Jan. 27, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage…

Bright Minds Biosciences Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

3 years ago

VANCOUVER, British Columbia, Jan. 27, 2023 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE:DRUG) (NASDAQ:DRUG) (“Bright Minds” or the “Company”)…

Spark Therapeutics Enters Into Strategic Collaboration with Neurochase for Use of Proprietary Delivery Technology for CNS Disorders

3 years ago

PHILADELPHIA, Jan. 27, 2023 (GLOBE NEWSWIRE) -- Spark Therapeutics, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY)…

Infant Bacterial Therapeutics publishes Annual Report for 2021 in XHTML format

3 years ago

On March 31 2022 IBT published the 2021 annual report in the format of a PDF file. Today, IBT publish…